BeiGene to Present at the RBC Capital Markets Global Healthcare Conference

Contributed by: Business Wire

Logo

Tags

Biotechnology

Pharmaceutical

Health

Oncology

Conference

More Like This

(Graphic: Business Wire)

BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer

BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference

BeiGene Announces First Quarter 2025 Financial Results and Business Updates

BeiGene Announces Appointment of Giancarlo Benelli as Head of Europe

BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program

U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene

BeiGene's flagship biologics manufacturing facility and clinical R&D center at the Princeton West Innovation Campus in Hopewell, N.J., is seen. (Photo: Business Wire)

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World

(Graphic: Business Wire)

BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates